Comparing Wound Complication Following TMA With Aid of Electrospun Fiber Matrix

NANot yet recruitingINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

March 31, 2024

Primary Completion Date

September 30, 2024

Study Completion Date

November 30, 2024

Conditions
AmputationWound; FootWound Complication
Interventions
DEVICE

Synthetic electrospun fiber matrix

Electrospun fiber matrices have long been investigated as an innovative construct for use in tissue engineering and regenerative medicine research due to their ability to mimic the structure and scale of native tissue. Clinical studies have demonstrated clinical efficacy in treating both chronic and acute wounds. There is strong evidence to support the application of a synthetic electrospun fiber matrix will generate favorable wound healing and reduce infection rates when used to augment transmetatarsal amputation.

All Listed Sponsors
collaborator

North Park Podiatry

OTHER

lead

Scripps Health

OTHER